ClinicalTrials.govpublic full text
Phase III Trial Of Docetaxel Versus Docetaxel Plus ZD1839 In Head And Neck Cancer
recurrent head and neck cancer, metastatic head and neck cancer, docetaxel, gefitinib, head and neck cancer, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 857941
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.